4basebio PLC (AIM:4BB)
London
· Delayed Price · Currency is GBP · Price in GBX 900.00
0.00 (0.00%)
Aug 15, 2025, 12:03 PM GMT+1
4basebio Market Cap
4basebio has a market cap or net worth of 139.30 million as of August 15, 2025. Its market cap has decreased by -20.31% in one year.
Market Cap
139.30M
Enterprise Value
119.68M
Revenue
933.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
900.00
Market Cap Chart
Since February 17, 2021, 4basebio's market cap has increased from 41.57M to 139.30M, an increase of 235.08%. That is a compound annual growth rate of 30.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 139.30M | -10.10% |
| Dec 31, 2024 | 154.94M | 84.96% |
| Dec 29, 2023 | 83.77M | -4.21% |
| Dec 30, 2022 | 87.45M | 15.45% |
| Dec 31, 2021 | 75.75M | 82.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 179.66B |
| GSK plc | 56.72B |
| Haleon | 32.11B |
| Smith & Nephew | 11.81B |
| ConvaTec Group | 4.67B |
| Hikma Pharmaceuticals | 3.96B |
| Oxford Nanopore Technologies | 2.04B |
| HUTCHMED (China) | 2.01B |